PEARLFECT LIMITEDActive
Key figures
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Turnover | 188,745 | 705,223 | 149,511 | — | 110,988 |
| Profit for the year | 25,465 | 38,635 | — | — | 12,087 |
| Total assets | 36,987 | 80,913 | 36,972 | 34,000 | 30,098 |
| Total liabilities | 25,520 | 30,809 | 31,237 | 26,840 | 10,847 |
| Net assets / total equity | 11,467 | 20,104 | 5,735 | 7,162 | 19,253 |
| Average number of employees | 10 | 5 | 2 | 2 | 1 |
| Average pay (per year) | 12,407 | 14,394 | — | — | 752 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Private Pharmacy Health check and screening Travel vaccinations Phlebotomy (urine and blood tests) Ear wax removal Private prescriptions Vaccinations Lung function test (Spirometry) General pharmaceutical services
As described in the company's latest filed accounts.
Summary: PEARLFECT LIMITED
Company
PEARLFECT LIMITED is a private limited company registered with Companies House under company number 07570715. It was incorporated on 21 Mar 2011. Its status is active. The registered office is in Aylesbury (HP19). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files micro-entity accounts. Turnover was £110,988. Profit for the year was £12,087. Net assets were £19,253, up 168.8% on the previous year. Total assets were £30,098 and total liabilities £10,847. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 12 Jan 2027.